Design, Synthesis, ADMET Prediction and Docking Studies of Novel Aryl and Heteroaryl Chalcones as CDK2 Inhibitors
International Journal of Pharmacy and Pharmaceutical Research · 2026 · 32 (2) · 261-272
DOI: 10.25166/ijppr.2026.32.2.30 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmacy and Pharmaceutical Research, 2026. Verfasst von Fathimathul Farisha K und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
K, F. F., KK, R., K, S., S, P., S, S., G, A., S, H., & L, B. (2026). Design, Synthesis, ADMET Prediction and Docking Studies of Novel Aryl and Heteroaryl Chalcones as CDK2 Inhibitors. International Journal of Pharmacy and Pharmaceutical Research, 32(2), 261-272. https://doi.org/10.25166/ijppr.2026.32.2.30
Vancouver
K FF, KK R, K S, S P, S S, G A, et al. Design, Synthesis, ADMET Prediction and Docking Studies of Novel Aryl and Heteroaryl Chalcones as CDK2 Inhibitors. International Journal of Pharmacy and Pharmaceutical Research. 2026;32(2):261-272. doi:10.25166/ijppr.2026.32.2.30
BibTeX
@article{K2026,
author = {K, Fathimathul Farisha and KK, Rushdiya and K, Shahana and S, Priyanka and S, Sangeetha and G, Adithya and S, Haripriya and L, Baskar},
title = {Design, Synthesis, ADMET Prediction and Docking Studies of Novel Aryl and Heteroaryl Chalcones as CDK2 Inhibitors},
journal = {International Journal of Pharmacy and Pharmaceutical Research},
year = {2026},
volume = {32},
number = {2},
pages = {261--272},
doi = {10.25166/ijppr.2026.32.2.30}
}
EUVIMED